Cargando…

Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718

Detalles Bibliográficos
Autores principales:	Pandey, Gaurav, Borcherding, Nicholas, Kolb, Ryan, Kluz, Paige, Li, Wei, Sugg, Sonia, Zhang, Jun, Lai, Dazhi A., Zhang, Weizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496922/ https://www.ncbi.nlm.nih.gov/pubmed/36139704 http://dx.doi.org/10.3390/cancers14184529

Ejemplares similares

ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer
por: Pandey, Gaurav, et al.
Publicado: (2019)

ROR1, an embryonic protein with an emerging role in cancer biology
por: Borcherding, Nicholas, et al.
Publicado: (2014)

Correction for Pandey et al., Infrastructure inequality is a characteristic of urbanization
Publicado: (2022)

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer
por: Borcherding, Nicholas, et al.
Publicado: (2015)

Erratum for Pandey et al., “Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori Enhances EBV-Induced Proliferation of Gastric Epithelial Cells”
por: Pandey, Saurabh, et al.
Publicado: (2020)

Cancer cell-intrinsic function of CD177 in attenuating β-Catenin signaling
por: Kluz, Paige N., et al.
Publicado: (2020)

Reply to Pandey: Possible functional impact of IgG3 allotype constant region
por: Kallolimath, Somanath, et al.
Publicado: (2022)

Contrasting roles of different mismatch repair proteins in basal-like breast cancer
por: Mo, Jiao, et al.
Publicado: (2023)

Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1
por: Cao, Jingying, et al.
Publicado: (2018)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1: Erratum
por: Cao, Jingying, et al.
Publicado: (2021)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Infection and immunity in farm animals: Edited by R. Pandey Basel: S. Karger. 1985. 255 pp. SFr. 164
por: Rutter, J.M.
Publicado: (1986)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Sung, Vanessa Y. C., et al.
Publicado: (2021)

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
por: Furugaki, Koh, et al.
Publicado: (2023)

Enhancing Mechanical Properties of the Spark Plasma Sintered Inconel 718 Alloy by Controlling the Nano-Scale Precipitations
por: Yan, Shuaijiang, et al.
Publicado: (2019)

Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering
por: Izadi, Arman, et al.
Publicado: (2023)

Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
por: Kolb, Ryan, et al.
Publicado: (2018)

Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
por: Kolb, Ryan, et al.
Publicado: (2020)

TRGAted: A web tool for survival analysis using protein data in the Cancer Genome Atlas.
por: Borcherding, Nicholas, et al.
Publicado: (2018)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Chondroitin Sulfates Control Invasiveness of the Basal-Like Breast Cancer Cell Line MDA-MB-231 Through ROR1
por: Nadanaka, Satomi, et al.
Publicado: (2022)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility
por: Luo, Chenglin, et al.
Publicado: (2018)

Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
por: Henry, Claire, et al.
Publicado: (2017)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Relevance Function of Linc-ROR in the Pathogenesis of Cancer
por: Chen, Wenjian, et al.
Publicado: (2020)

ROR2 Is Epigenetically Regulated in Endometrial Cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Bone Marrow Stromal Antigen 2 (BST-2) DNA Is Demethylated in Breast Tumors and Breast Cancer Cells
por: Mahauad-Fernandez, Wadie D., et al.
Publicado: (2015)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Identification of RORγ as a favorable biomarker for colon cancer
por: Pan, Xiaofei, et al.
Publicado: (2021)

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer()
por: Henry, CE, et al.
Publicado: (2017)

FGFR2 is required for airway basal cell self-renewal and terminal differentiation
por: Balasooriya, Gayan I., et al.
Publicado: (2017)

Aluminide Diffusion Coatings on IN 718 by Pack Cementation
por: Cojocaru, Mihai Ovidiu, et al.
Publicado: (2022)

Distinct functions and prognostic values of RORs in gastric cancer
por: Gu, Feng, et al.
Publicado: (2020)

The roles of Linc-ROR in the regulation of cancer stem cells
por: Wen, Xiaoling, et al.
Publicado: (2022)

Infection and Immunity in Farm Animals: R. Pandey (Editor). S. Karger AG, Basel, 1985, 258 pp., US$98.25, ISBN 3-8055-3925-8.
por: Becht, H.
Publicado: (1985)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Kim, Myung-Chul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jfd9s3rchg0hf1l404oqcjpakp